Ascendis Reports Second Quarter 2017 Financial Results
(WorldNews Denmark)

COPENHAGEN, Denmark, Aug. 18, 2017 -- Ascendis Pharma A/S , a biopharmaceutical company that utilizes its innovative TransCon technology to address significant unmet medical needs in rare diseases, today announced financial results for the quarter ended June 30, 2017. `We are making excellent progress executing our Vision 20/20 strategic plan to establish Ascendis as a leading, integrated rare disease company,` said Jan Mikkelsen, Ascendis Pharma`s President and Chief Executive Officer. ......